Stryker Corp
NYSE:SYK
Relative Value
The Relative Value of one
SYK
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 366.53 USD,
Stryker Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SYK Competitors Multiples
Stryker Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Stryker Corp
NYSE:SYK
|
139.2B USD | 5.6 | 43.2 | 21.9 | 26.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.1B USD | 4.3 | 29.1 | 16.5 | 22.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.1B USD | 17.2 | 60.5 | 46.1 | 55.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.6B USD | 3.8 | 28 | 15.6 | 22.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.9B USD | 5.9 | 41 | 24.4 | 33.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.3B USD | 2.7 | 35.3 | 12.9 | 22 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR | 2 | 22 | 12.5 | 17.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51B USD | 11.9 | 48.3 | 34.5 | 38.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 7.8 | 33.6 | 23.9 | 26.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
38.3B USD | 7.2 | 26.1 | 18.5 | 20.5 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.8B USD | 1.9 | 17 | 12.7 | 15.4 |